Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Sidoti & Co. Upgrades Staar Surgical to Buy

Sidoti & Co. Upgrades Staar Surgical to Buy

Sidoti & Co. analyst James Sidoti upgrades Staar Surgical (NASDAQ:STAA) from Neutral to Buy.

byBenzinga Newsdesk

November 7, 2022

1 minute read

Sidoti & Co. analyst James Sidoti upgrades Staar Surgical (NASDAQ:STAA) from Neutral to Buy.

Barclays Maintains Underweight on Silicon Laboratories, Raises Price Target to $100

By Benzinga Newsdesk

January 23, 7:59 AM

Barclays analyst Blayne Curtis maintains Silicon Laboratories (NASDAQ:SLAB) with a Underweight and raises the price target from $85 to $100.

SLAB

Truist Securities Downgrades PacWest Banc to Hold, Announces $26 Price Target

By Benzinga Newsdesk

December 9, 8:24 AM

Truist Securities analyst Brandon King downgrades PacWest Banc (NASDAQ:PACW) from Buy to Hold and announces $26 price target.

PACW

XPeng Begins Shipping 750 Vehicles To Israel: Report

By Nabaparna Bhattacharya

September 26, 12:40 PM

XPeng Inc. (NYSE: XPEV) has reportedly started dispatching hundreds of electric vehicles (EVs) to Israel after the Chinese firm revealed strategies to enter the Middle Eastern country in July.

XPEV

Piper Sandler Maintains Overweight on Blackstone, Lowers Price Target to $154

By Benzinga Newsdesk

July 11, 6:46 AM

Piper Sandler analyst Sumeet Mody maintains Blackstone (NYSE:BX) with a Overweight and lowers the price target from $169 to $154.

Sidoti & Co. Upgrades Staar Surgical to Buy

Related Posts

Barclays Maintains Underweight on Silicon Laboratories, Raises Price Target to $100

Truist Securities Downgrades PacWest Banc to Hold, Announces $26 Price Target

XPeng Begins Shipping 750 Vehicles To Israel: Report

Piper Sandler Maintains Overweight on Blackstone, Lowers Price Target to $154